[MYGN] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
08-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 528.68%
YoY- 6,858.33%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 200,900 193,500 194,000 190,200 200,500 196,900 196,500 1.49%
PBT 16,100 16,500 3,700 86,600 18,800 8,000 12,100 21.03%
Tax 3,000 5,200 -28,400 5,600 6,100 3,800 6,200 -38.44%
NP 13,100 11,400 32,100 81,100 12,900 4,200 5,900 70.44%
Tax Rate -18.63% -31.52% 767.57% -6.47% -32.45% -47.50% -51.24% -
Total Cost 187,800 182,100 161,900 109,100 187,600 192,700 190,600 -0.98%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 6.52 5.89 16.55 42.64 6.43 2.13 3.00 68.02%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS 0.19 0.16 0.46 1.18 0.19 0.06 0.09 64.79%
EPS Diluted 0.18 0.16 0.45 1.15 0.19 0.06 0.09 58.94%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.